These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24625506)

  • 1. Long-term efficacy of infliximab in autoimmune sensorineural hearing loss associated with rheumatoid arthritis.
    Gazeau P; Saraux A; Devauchelle-Pensec V; Cornec D
    Rheumatology (Oxford); 2014 Sep; 53(9):1715-6. PubMed ID: 24625506
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of adalimumab in treatment of autoimmune sensorineural hearing loss: a word of caution.
    Conway R; Khan S; Foley-Nolan D
    J Rheumatol; 2011 Jan; 38(1):176; author reply 176. PubMed ID: 21196585
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment-refractory autoimmune sensorineural hearing loss: response to infliximab.
    Liu YC; Rubin R; Sataloff RT
    Ear Nose Throat J; 2011 Jan; 90(1):23-8. PubMed ID: 21229506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of adalimumab for treating rheumatoid arthritis with autoimmune sensorineural hearing loss: two birds with one stone.
    Morovic Vergles J; Radic M; Kovacic J; Salamon L
    J Rheumatol; 2010 May; 37(5):1080-1. PubMed ID: 20439536
    [No Abstract]   [Full Text] [Related]  

  • 5. Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss.
    Van Wijk F; Staecker H; Keithley E; Lefebvre PP
    Audiol Neurootol; 2006; 11(6):357-65. PubMed ID: 16988499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab for autoimmune inner ear disease: case report and literature review.
    Heywood RL; Hadavi S; Donnelly S; Patel N
    J Laryngol Otol; 2013 Nov; 127(11):1145-7. PubMed ID: 24125068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for rheumatoid arthritis in a patient with tuberculosis.
    Matsumoto T; Tanaka T; Kawase I
    N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on rituximab.
    Eisenberg R
    Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv55-7. PubMed ID: 16239389
    [No Abstract]   [Full Text] [Related]  

  • 10. DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis.
    van Riel PL; Fransen J
    Arthritis Res Ther; 2005; 7(5):189-90. PubMed ID: 16207346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis and auto-immune hearing loss. A case study.
    Nores JM; Bonfils P
    Clin Rheumatol; 1988 Dec; 7(4):520-1. PubMed ID: 3246136
    [No Abstract]   [Full Text] [Related]  

  • 12. Open trial of methotrexate as treatment for autoimmune hearing loss.
    Matteson EL; Fabry DA; Facer GW; Beatty CW; Driscoll CL; Strome SE; McDonald TJ
    Arthritis Rheum; 2001 Apr; 45(2):146-50. PubMed ID: 11324778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis.
    Bargagli E; Galeazzi M; Rottoli P
    Eur Respir J; 2004 Oct; 24(4):708. PubMed ID: 15459153
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of infliximab for intralymphatic histiocytosis with rheumatoid arthritis.
    Sakaguchi M; Nagai H; Tsuji G; Morinobu A; Kumagai S; Nishigori C
    Arch Dermatol; 2011 Jan; 147(1):131-3. PubMed ID: 21242414
    [No Abstract]   [Full Text] [Related]  

  • 15. Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy.
    Ashok D; Ayliffe WH; Kiely PD
    Rheumatology (Oxford); 2005 Jul; 44(7):950-1. PubMed ID: 15827040
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate therapy for autoimmune hearing loss: a preliminary report.
    Sismanis A; Thompson T; Willis HE
    Laryngoscope; 1994 Aug; 104(8 Pt 1):932-4. PubMed ID: 8052076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of rheumatoid meningitis with cyclophosphamide but not infliximab.
    Chou RC; Henson JW; Tian D; Hedley-Whyte ET; Reginato AM
    Ann Rheum Dis; 2006 Aug; 65(8):1114-6. PubMed ID: 16837495
    [No Abstract]   [Full Text] [Related]  

  • 18. Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis.
    Eekman DA; Vis M; Bultink IE; Kuik DJ; Voskuyl AE; Dijkmans BA; Lems WF
    Ann Rheum Dis; 2011 Feb; 70(2):389-90. PubMed ID: 20447956
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab for treatment of scleritis associated with rheumatoid arthritis.
    Chauhan S; Kamal A; Thompson RN; Estrach C; Moots RJ
    Br J Ophthalmol; 2009 Jul; 93(7):984-5. PubMed ID: 19553514
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis.
    Boulman N; Rozenbaum M; Slobodin G; Rosner I
    Clin Exp Rheumatol; 2006; 24(6):723. PubMed ID: 17207395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.